Imaging assessment of the activity and treatment efficacy of thyroid associated ophthalmopathy

VernacularTitle:甲状腺相关性眼病活动性和疗效的影像学评估
Author: Yu LIU ¹ ; Mengting LI ; Hong CHEN ; Wei LIU ; Ying DING ; Li ZHANG ; Yinqian DENG ; Huanyu CHEN ; Min ZHAO ; Xiaotian XIA ; Wei CAO
Author Information

1. 华中科技大学同济医学院附属协和医院核医学科、分子影像湖北省重点实验室、生物靶向治疗教育部重点实验室，武汉　430022
Keywords: Graves ophthalmopathy; Ultrasonography; Tomography, X-ray computed; Magnetic resonance imaging; Radionuclide imaging; Trends
From: Chinese Journal of Nuclear Medicine and Molecular Imaging 2024;44(10):628-632
CountryChina
Language:Chinese
Abstract: Thyroid associated ophthalmopathy (TAO) is an organ-specific autoimmune disease. TAO is clinically classified into active and inactive stage, and the accurate judgment is the key point of treatment choice. Clinical activity score (CAS) is often used for the assessment of TAO activity, which is subjective to some extent. With the development of imaging techniques, ultrasonography, CT, MRI and radionuclide imaging have gradually been applied into the diagnosis and treatment of TAO. What′s more, the imaging is an important complement to CAS from the aspects of anatomical and functional metabolism, which can better assess the activity and the therapy response of TAO. The clinical value of medical imaging in activity and treatment efficacy evaluation of TAO is reviewed in this article.